This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: I-Sens, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Ye Jeong Lee: Innovator in Biometric Information Transmission
Introduction
Ye Jeong Lee is a prominent inventor based in Seoul, South Korea. She has made significant contributions to the field of biometric information transmission, particularly in continuous glucose monitoring systems. Her innovative approach aims to enhance the efficiency and reliability of data transmission in medical devices.
Latest Patents
Ye Jeong Lee holds a patent for a method titled "Method for transmitting and receiving biometric information without loss based on transmission packet identifier in continuous blood glucose monitor system." This patent focuses on a technique for transmitting and receiving biometric information, ensuring that data generated by the sensor transmitter is sent to the communication terminal without loss. The method involves transmitting an identifier of the last transmit packet received, allowing for seamless communication in each cycle.
Career Highlights
Ye Jeong Lee is associated with I-Sens, Inc., a company known for its advancements in glucose monitoring technology. Her work has been instrumental in developing solutions that improve patient care and monitoring accuracy. With her expertise, she has contributed to the evolution of medical devices that are crucial for diabetes management.
Collaborations
Ye Jeong Lee has collaborated with notable colleagues, including Choong Beom You and Hun Woo Heo. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the field of biometric technology.
Conclusion
Ye Jeong Lee's contributions to biometric information transmission exemplify her commitment to advancing medical technology. Her innovative methods are paving the way for more effective glucose monitoring systems, ultimately benefiting patients worldwide.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
